Drug access extended for patients in previous trials
NCT ID NCT04640025
Summary
This study allows people who were already receiving itacitinib in previous clinical trials to continue taking the medication. It's for adults with myelofibrosis, chronic graft-versus-host disease, or lung transplant complications who were benefiting from the drug in earlier studies. Participants will keep taking the same dose they were on before, as long as they continue to tolerate it well and show benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anschutz Cancer Pavilion-University of Colorado
Aurora, Colorado, 80045, United States
-
Aou San Giovanni Di Dio E Ruggi
Salerno, 84131, Italy
-
Azienda Ospedaliera Bianchi-Melacrino-Morelli Ospedali Riuniti
Reggio Calabria, 89100, Italy
-
Azienda Policlinico Vittorio Emanuele
Catania, 95123, Italy
-
City of Hope National Medical Center
Duarte, California, 31010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Hadassah Hebrew University Medical Center Ein Karem Hadassah
Jerusalem, 91120, Israel
-
Hospital Universitario Ramon Y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Virgen de Las Nieves
Granada, 18012, Spain
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Ordensklinikum Linz Gmbh Elisabethinen
Linz, 04020, Austria
-
Parkview Cancer Institute
Fort Wayne, Indiana, 46845, United States
-
Providence Health
Vancouver, British Columbia, V6Z 2A5, Canada
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Temple University Department of Thoracic Medicine and Surgery
Philadelphia, Pennsylvania, 19140, United States
-
Texas Oncology San Antonio
San Antonio, Texas, 78240, United States
-
Universitaire Ziekenhuis Leuven - Gasthuisberg
Leuven, 03000, Belgium
-
Universitatsklinikum Halle (Saale)
Halle, D06120, Germany
-
University Hospital Mannheim
Mannheim, 68167, Germany
-
University Hospital of West Attica - Attikon
Chaïdári, 12462, Greece
-
University Medical Centre Hamburg-Eppendorf Centre of Oncology
Hamburg, 20251, Germany
Conditions
Explore the condition pages connected to this study.